Scinai Immunotherapeutics Ltd Share Price Today: Live Updates & Key Insights

Scinai Immunotherapeutics Ltd share price today is $0.7076, up 0.37%. The stock opened at $0.7075 against the previous close of $0.705, with an intraday high of $0.7075 and low of $0.7075.

Scinai Immunotherapeutics Ltd Share Price Chart

Scinai Immunotherapeutics Ltd

us-stock
To Invest in {{usstockname}}
us-stock

Scinai Immunotherapeutics Ltd Share Price Performance

$0.7076 0.0037(0.37%) SCNI at 23 Mar 2026 03:09 PM Biotechnology
Lowest Today 0.7075
Highest Today 0.7075
Today’s Open 0.7075
Prev. Close 0.705
52 Week High 3.92
52 Week Low 0.61
Day’s Range: Low 0.7075 High 0.7075
52-Week Range: Low 0.61 High 3.92
1 day return -
1 Week return -
1 month return -20.77
3 month return +7.36
6 month return -51.72
1 year return -79.28
3 year return -96.8
5 year return -99.82
10 year return -

Scinai Immunotherapeutics Ltd Institutional Holdings

Scinai Immunotherapeutics Ltd Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Scinai Immunotherapeutics Ltd Fundamentals

Market Cap 2.26 M

PB Ratio 1.1

PE Ratio 0.1769

Enterprise Value 9.45 M

Total Assets 13.45 M

Volume 8123

Scinai Immunotherapeutics Ltd Company Financials

Annual Revenue FY23:0 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-9286000 -9.3M, FY22:-5796000 -5.8M, FY21:-39978000 -40.0M, FY20:-1385455 -1.4M, FY19:-109194000 -109.2M

Quarterly Revenue Q3/2025:277290 0.3M, Q2/2025:386500 0.4M, Q1/2025:386500 0.4M, Q3/2024:168000 0.2M, Q2/2024:284000 0.3M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-635000 -0.6M, Q1/2025:-635000 -0.6M, Q3/2024:-249000 -0.2M, Q2/2024:-164000 -0.2M

Quarterly Net worth Q3/2025:-2119868 -2.1M, Q2/2025:-2067000 -2.1M, Q1/2025:-1549000 -1.5M, Q3/2024:10455000 10.5M, Q2/2024:-2322000 -2.3M

About Scinai Immunotherapeutics Ltd & investment objective

Company Information Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel. It develops nanosized VHH antibodies (nanoAbs) targeting diseases with unmet medical needs; and PC111, a monoclonal antibody for treating pemphigus, steven johnson's syndrome, and toxic epidermal necrolysis. The company also provides contract development and manufacturing organization services to biotech companies. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Gottingen for the development and commercialization of COVID-19 nanosized antibody. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.

Organisation Biotechnology

Employees 31

Industry Biotechnology

CEO Mr. Amir Reichman M.B.A., M.Sc.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Scinai Immunotherapeutics Ltd FAQs

What is the share price of Scinai Immunotherapeutics Ltd today?

The current share price of Scinai Immunotherapeutics Ltd is $0.7076.

Can I buy Scinai Immunotherapeutics Ltd shares in India?

Yes, Indian investors can buy Scinai Immunotherapeutics Ltd shares by opening an international trading and demat account with Motilal Oswal.

How to buy Scinai Immunotherapeutics Ltd shares in India?

You can easily invest in Scinai Immunotherapeutics Ltd shares from India by:

Can I buy fractional shares of Scinai Immunotherapeutics Ltd?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Scinai Immunotherapeutics Ltd?

Scinai Immunotherapeutics Ltd has a market cap of $2.26 M.

In which sector does Scinai Immunotherapeutics Ltd belong?

Scinai Immunotherapeutics Ltd operates in the Biotechnology sector.

What documents are required to invest in Scinai Immunotherapeutics Ltd stocks?

To invest, you typically need:

What is the PE and PB ratio of Scinai Immunotherapeutics Ltd?

The PE ratio of Scinai Immunotherapeutics Ltd is 0.18 and the PB ratio is 1.10.